Marinus Pharma Stock (NASDAQ: MRNS) stock price, news, charts, stock research, profile.
Open | $8.910 |
Close | $9.040 |
Volume / Avg. | 869.000K / 425.832K |
Day Range | 8.825 - 9.240 |
52 Wk Range | 5.570 - 11.260 |
Market Cap | $493.969M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 6.58% |
Days to Cover | 12.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marinus Pharma (NASDAQ: MRNS) through any online brokerage.
Other companies in Marinus Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
The latest price target for Marinus Pharma (NASDAQ: MRNS) was reported by HC Wainwright & Co. on Tuesday, March 26, 2024. The analyst firm set a price target for 27.00 expecting MRNS to rise to within 12 months (a possible 198.67% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Marinus Pharma (NASDAQ: MRNS) is $9.04 last updated March 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Marinus Pharma.
Marinus Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Marinus Pharma.
Marinus Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.